28 filings
8-K
ICVX
Icosavax Inc
20 Feb 24
Completion of Acquisition or Disposition of Assets
8:42am
8-K
ICVX
Icosavax Inc
12 Dec 23
Tender and Support Agreement
4:12pm
8-K
ICVX
Icosavax Inc
14 Nov 23
Icosavax Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:17pm
8-K
ICVX
Icosavax Inc
14 Aug 23
Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:13pm
8-K
ICVX
Icosavax Inc
8 Aug 23
Regulation FD Disclosure
4:15pm
8-K
wrxyqbed
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
6144ucdeut6gz6s
23 May 23
Entry into a Material Definitive Agreement
6:09am
8-K
7o97ckwljrtpw2qo8f9
22 May 23
Regulation FD Disclosure
5:12pm
8-K
ustxp9dd6x rj170ik8
10 May 23
Icosavax Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:18pm
8-K
m1s7 ywag1xehu
30 Mar 23
Icosavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
4:14pm
8-K
gd1q6i j0bo35pavxgru
13 Dec 22
Other Events
4:13pm
8-K
d4w9o09
14 Nov 22
Icosavax Reports Third Quarter Financial Results and Provides
12:00am
8-K
n7uizvc9b
15 Aug 22
Icosavax Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:40pm
8-K
h3zxgzvifj15gkw
28 Jun 22
Icosavax Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Candidate IVX-121 Against RSV
4:10pm
8-K
wtrlh6 f72rx9ipyq
15 Jun 22
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
rqzsjtqag
16 May 22
Icosavax Reports First Quarter 2022 Financial Results and Provides Corporate Update
12:00am
8-K
s8iuwaxp2l6 ioj
25 Apr 22
Regulation FD Disclosure
8:01am
8-K
s1o31f3v 7i6i2wmq
30 Mar 22
Icosavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:39pm
8-K
9mfq9l0nq11mss1hn
25 Mar 22
Other Events
8:09am
8-K
e2r6sdqpo070u vb
11 Feb 22
Departure of Directors or Certain Officers
5:20pm